Key Factors
- Eric Lefkofsky offered 166,250 Tempus AI shares on Nov. 20 at a mean worth of $68.97 for about $11.47 million, trimming his stake by 1.81% to 9,041,283 shares valued at roughly $623.6 million.
- Tempus reported a Q that beat expectations—loss per share of $0.11 vs. a $0.16 loss estimate and income of $334.2 million (up 84.7% YoY)—however nonetheless reveals a damaging internet margin (-18.45%) and damaging ROE (-73.21%).
- The inventory is risky (52-week vary $31.36–$104.32) and was down about 4.9% on the most recent session; analysts are cut up with a mean score of Maintain and a mean goal worth of $80.00.
Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) EVP Andrew Polovin offered 5,205 shares of the corporate’s inventory in a transaction dated Tuesday, November 18th. The inventory was offered at a mean worth of $65.54, for a complete transaction of $341,135.70. Following the completion of the sale, the manager vp immediately owned 126,851 shares within the firm, valued at roughly $8,313,814.54. The commerce was a 3.94% lower of their place. The transaction was disclosed in a authorized submitting with the SEC, which may be accessed by means of this link.
Andrew Polovin additionally lately made the next commerce(s):
- On Wednesday, November nineteenth, Andrew Polovin offered 6,387 shares of Tempus AI inventory. The shares had been offered at a mean worth of $68.06, for a complete transaction of $434,699.22.
Tempus AI Value Efficiency
NASDAQ:TEM opened at $67.91 on Friday. The corporate has a fast ratio of three.12, a present ratio of three.28 and a debt-to-equity ratio of two.45. The agency has a market cap of $12.08 billion, a PE ratio of -57.07 and a beta of 4.86. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month excessive of $104.32. The corporate’s 50-day shifting common worth is $83.96 and its two-hundred day shifting common worth is $71.87.
Tempus AI (NASDAQ:TEM – Get Free Report) final posted its quarterly earnings knowledge on Tuesday, November 4th. The corporate reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.05. Tempus AI had a damaging internet margin of 18.45% and a damaging return on fairness of 73.21%. The corporate had income of $334.21 million through the quarter, in comparison with analyst estimates of $328.89 million. Throughout the identical quarter final 12 months, the enterprise posted ($0.46) earnings per share. The corporate’s income was up 84.7% on a year-over-year foundation. Tempus AI has set its FY 2025 steerage at EPS. On common, equities analysts anticipate that Tempus AI, Inc. will publish -6.15 EPS for the present fiscal 12 months.
Institutional Inflows and Outflows
A number of hedge funds have lately modified their holdings of the enterprise. ARK Funding Administration LLC lifted its stake in shares of Tempus AI by 35.9% within the 1st quarter. ARK Funding Administration LLC now owns 7,501,399 shares of the corporate’s inventory valued at $361,867,000 after buying an extra 1,981,755 shares through the interval. Vanguard Group Inc. elevated its holdings in Tempus AI by 6,247.5% within the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the corporate’s inventory valued at $289,204,000 after buying an extra 5,900,668 shares over the past quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd elevated its holdings in Tempus AI by 109.9% within the first quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 50,666 shares of the corporate’s inventory valued at $2,444,000 after buying an extra 26,533 shares over the past quarter. Bounce Monetary LLC acquired a brand new place in Tempus AI within the first quarter valued at about $8,545,000. Lastly, Tyler Stone Wealth Administration purchased a brand new place in Tempus AI through the first quarter price about $386,000. Institutional buyers personal 24.22% of the corporate’s inventory.
Analyst Scores Modifications
A number of brokerages have issued studies on TEM. TD Cowen downgraded Tempus AI from a “purchase” score to a “maintain” score and set a $88.00 worth goal for the corporate. in a analysis report on Tuesday, October twenty first. Weiss Ratings restated a “promote (d-)” score on shares of Tempus AI in a analysis notice on Wednesday, October eighth. Morgan Stanley upped their worth goal on shares of Tempus AI from $68.00 to $80.00 and gave the inventory an “chubby” score in a analysis report on Tuesday, November eleventh. Canaccord Genuity Group decreased their worth goal on shares of Tempus AI from $110.00 to $95.00 and set a “purchase” score on the inventory in a report on Wednesday, November fifth. Lastly, Guggenheim raised their worth goal on shares of Tempus AI from $80.00 to $95.00 and gave the corporate a “purchase” score in a analysis report on Friday, September twenty sixth. Seven funding analysts have rated the inventory with a Purchase score, seven have issued a Maintain score and one has given a Promote score to the corporate. In response to MarketBeat, the corporate has a consensus score of “Maintain” and a mean goal worth of $80.00.
Get Our Latest Analysis on Tempus AI
About Tempus AI
Tempus AI Inc is a expertise firm advancing precision medication by means of the sensible utility of synthetic intelligence principally in healthcare. The corporate gives AI-enabled precision medication options to physicians to ship personalised affected person care and in parallel facilitates discovery, improvement and supply of optimum therapeutics.
Featured Articles
This immediate information alert was generated by narrative science expertise and monetary knowledge from InsiderTrades.com with a view to present readers with the quickest and most correct reporting. Please ship any questions or feedback about this story to [email protected].
